drugset / Trial / NCT01329991
Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate
RandomizedSingle-groupQuadruple-blindTreatment
Summary
PLX115-02 is a phase 1b study to assess how the study drug, PLX5622: 1. affects the body, 2. how the body affects PLX5622 3. the interaction of PLX5622 with Methotrexate and 4. the safety of PLX5622 in rheumatoid arthritis patients taking Methotrexate
Timeline
- Start
- 2011-05
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PLX5622 | Small molecule | 200 mg | Oral |
| Comparator | PLX5622 | Small molecule | 400 mg | Oral |
| Comparator | PLX5622 | Small molecule | 800 mg | Oral |